Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain

BACKGROUND: Antiplatelet therapy with aspirin (acetylsalicylic acid [ASA]) is less efficient in some coronary patients, which increases their risk of developing thrombosis. Elevated blood levels of thromboinflammatory mediators, like soluble CD40L (sCD40L), may explain such variabilities. We hypothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kojok, Kevin, Mohsen, Mira, El Kadiry, Abed El Hakim, Mourad, Walid, Merhi, Yahye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033871/
https://www.ncbi.nlm.nih.gov/pubmed/32009527
http://dx.doi.org/10.1161/JAHA.119.013396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033871/
https://www.ncbi.nlm.nih.gov/pubmed/32009527
http://dx.doi.org/10.1161/JAHA.119.013396

Ejemplares similares